Latest News and Press Releases
Want to stay updated on the latest news?
-
Alithia Intelligent Alliance Office Announces Completion of a Key Phase in Its Digital Platform Development
-
Julie & Holleman LLP is investigating potential misconduct committed by Fiserv's directors and officers.
-
Julie & Holleman LLP is investigating potential misconduct at Stride, Inc.
-
Julie & Holleman LLP is investigating potential misconduct by KinderCare's officers and directors.
-
SINGAPORE, Jan. 07, 2026 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (NASDAQ: EUDA) “EUDA” or “the Company”, a Singapore-based non-invasive healthcare provider in Asia focused on Singapore,...
-
HIGHTITAN Trading Center Improves Multilingual User Support Processes
-
Did Jefferies Financial Group Inc. Mislead Investors? Contact BFA Law about its Ongoing Securities Fraud Investigation if You Suffered Losses
-
3 E Network (Nasdaq: MASK), announced a convertible note financing of up to $2.0 million.
-
CERo Therapeutics Provides Clinical Update on Phase 1 Clinical Trial of CER-1236 in AML (CertainT-1)
Completion of DLT observation period for Cohort 1; first patient in Cohort 2 dosed at higher cell level; additional dosing in Cohort 1 SOUTH SAN FRANCISCO, Calif., Dec. 17, 2025 (GLOBE NEWSWIRE) --...
-
Vancouver, Canada, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on the discovery and...